Hypothalamitis and severe hypothalamic dysfunction associated with anti–programmed cell death ligand 1 antibody treatment
Autor: | Tshuma, N., Glynn, N., Evanson, J., Powles, T., Drake, W.M. |
---|---|
Zdroj: | In European Journal of Cancer November 2018 104:247-249 |
Databáze: | ScienceDirect |
Externí odkaz: |